***Background.*** The pre-travel counseling visit represents an ideal opportunity for updating routine and destination specific immunizations. The American College of Immunization Practices (ACIP) recommends pneumococcal vaccination (PPSV) for adults ≥ 65 years and Zostavax in those ≥ 60 years. Recent updates also recommend Hepatitis B vaccination for diabetics. To examine coverage and factors associated with the failure to address routine adult vaccinations listed above, we analyzed data collected in the TravMil study at the pre-travel visit.

***Methods.*** The TravMil cohort is comprised of DoD beneficiaries evaluated pre-travel at 3 military travel clinics (Walter Reed National Military Medical Center (WRNMMC), National Naval Medical Center San-Diego (NMCSD), and Naval Medical Center Portsmouth (NMCP)). Vaccination status and vaccine prescriptions were evaluated. Multivariate Poisson regression with robust error variance was used to examine factors associated with failure to immunize adults who met criteria for immunization with PPSV, Zostavax, and Hepatitis B.

***Results.*** Non-white race \[RR: 1.42 (1.04-1.92)\] was associated with a failure to vaccinate with Zostavax and/or PPSV, as was evaluation at NMCP \[Ref WRNMMC; RR 2.46 (1.43-4.24)\]. Female diabetics were less likely to receive Hepatitis B vaccination \[RR: 1.60 (1.08-2.39)\].

  Vaccine Status                     Overall     WRNMMC     NMCP       NMCSD
  ---------------------------------- ----------- ---------- ---------- -----------
  **Hepatitis B in Diabetics**       n=86        n=8        n=29       n=49
  Up to date                         26(30.2)    5(62.5)    5(17.2)    16(32.7)
  Administered at pre-travel visit   14(16.3)    1(7.1)     9(31.0)    4(8.2)
  **PPSV in adults ≥65**             n=352       n=39       n=97       n=216
  Up to date                         241(68.5)   29(74.4)   59(60.8)   153(70.8)
  Administered at pre-travel visit   72(20.5)    9(23.1)    22(22.7)   41(19.0)
  **Zostavax in adults ≥60**         n=477       n=54       n=139      n=284
  Up to date                         301(63.1)   39(72.2)   72(51.8)   190(66.9)
  Administered at pre-travel visit   41(8.6)     5(9.3)     3(2.2)     33(11.6)

***Conclusion.*** Even in a setting with free access to care and vaccinations, significant variability in coverage of recommended vaccines was noted by race, gender and clinic site. Factors associated with these differences need to be studied further.
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